Malignant Intracranial Neoplasm — Trials

Malignant Intracranial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

637 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 192
Recruiting: 110
Ph III recruiting: 4
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (100)

clinicaltrialsPublishedShowing 1–50 of 135 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07326566	Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII	recruiting	Phase 2	162	Black Diamond Therapeutics, Inc.INDUSTRY	1	Sep 28, 2026	clinicaltrials
NCT07346157	Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease(PNOC044)	recruiting	Phase 1 / Phase 2	69	Sabine Mueller, MD, PhDOTHER	1	Sep 28, 2026